These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14128471)

  • 1. A PROGESTATIONAL AGENT (MEDROXYPROGESTERONE ACETATE) IN TREATMENT OF PRIMARY ADENOCARCINOMA OF THE CERVIX. REPORT OF A CASE.
    MADDEN EP
    Obstet Gynecol; 1964 Mar; 23():409-12. PubMed ID: 14128471
    [No Abstract]   [Full Text] [Related]  

  • 2. PROGESTERONE AND PROGESTATIONAL COMPOUNDS IN THE TREATMENT OF ADVANCED ENDOMETRIAL CARCINOMA.
    BERGSJOE P
    Acta Endocrinol (Copenh); 1965 Jul; 49():412-26. PubMed ID: 14317884
    [No Abstract]   [Full Text] [Related]  

  • 3. Endolymphatic stromal myosis with pulmonary metastases. Remission with progestin therapy: report of a case.
    Krumholz BA; Lobovsky FY; Halitsky V
    J Reprod Med; 1973 Feb; 10(2):85-9. PubMed ID: 4697437
    [No Abstract]   [Full Text] [Related]  

  • 4. PROGESTATIONAL DRUGS IN THE MANAGEMENT OF ENDOMETRIAL CANCER.
    FRICK HC
    Metabolism; 1965 Mar; 14():SUPPL:348-55. PubMed ID: 14261421
    [No Abstract]   [Full Text] [Related]  

  • 5. Medroxyprogesterone acetate modulates remodeling, immune cell census, and nerve fibers in the cervix of a mouse model for inflammation-induced preterm birth.
    Yellon SM; Ebner CA; Elovitz MA
    Reprod Sci; 2009 Mar; 16(3):257-64. PubMed ID: 19087974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of endometrial activity after radiation therapy for cervical carcinoma.
    Barnhill D; Heller P; Dames J; Hoskins W; Gallup D; Park R
    Obstet Gynecol; 1985 Dec; 66(6):805-8. PubMed ID: 2999661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MANAGEMENT OF ADVANCED ENDOMETRIAL ADENOCARCINOMA WITH MEDROXYPROGESTERONE ACETATE.
    ANDERSON DG
    Am J Obstet Gynecol; 1965 May; 92():87-99. PubMed ID: 14280914
    [No Abstract]   [Full Text] [Related]  

  • 8. Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation?
    Elovitz MA; Mrinalini C
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1149-55. PubMed ID: 16157128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MESONEPHROGENIC ADENOCARCINOMA AND ADENOMA OF THE CERVIX].
    TOTH F; CSOEMOER S; MESZAROS J
    Orv Hetil; 1964 Jan; 105():31-3. PubMed ID: 14135855
    [No Abstract]   [Full Text] [Related]  

  • 10. [UTERINE NEOPLASMS AND URINARY TRACT DISORDERS].
    SATO S; YOSHIMURA K; MACHIKAZE Y; OHKOSHI M; SUGA K; ISHIKAWA T; ISHIYAMA S; KASUGA S
    Rinsho Hoshasen; 1964 Jul; 9():574-80. PubMed ID: 14197557
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of progestational agents in endometrial adenocarcinoma.
    Rozier JC; Underwood PB
    Obstet Gynecol; 1974 Jul; 44(1):60-4. PubMed ID: 4834800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal cytologic evaluation as a practical link between hormone blood levels and tumor hormone dependency in exclusive medroxyprogesterone treatment of recurrent or metastatic endometrial adenocarcinoma.
    Bonte J; Decoster JM; Ide P
    Acta Cytol; 1977; 21(2):218-24. PubMed ID: 266331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
    Kline RC; Freedman RS; Jones LA; Atkinson EN
    Cancer Treat Rep; 1987 Mar; 71(3):327-8. PubMed ID: 2949831
    [No Abstract]   [Full Text] [Related]  

  • 14. [A ROENTGENOGRAPHIC STUDY ON THE GROWTH RATES OF LUNG TUMORS].
    TOBE T; KATO T; SAITO S; HIRAI E; NIIZUMA S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1964 Jul; 24():426-32. PubMed ID: 14193311
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combination with medroxyprogesterone acetate and chemotherapy making possible complete removal of uterine corpus carcinoma].
    Tajima H; Okada T; Fujimori Y; Tomioka Y; Hirano M; Yoshida T; Ikeda S; Hata T
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2461-4. PubMed ID: 2526620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestational agents in advanced breast cancer: an overview.
    Haller DG; Glick JH
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):2-8. PubMed ID: 3026051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [URETERAL METASTASIS DUE TO CERVICOUTERINE CANCER].
    MALDONADO J
    Rev Mex Urol; 1964; 23():349-50. PubMed ID: 14183667
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of advanced cancers of the cervix with medroxprogesterone].
    Van Exter C; Pauls F
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):383-4. PubMed ID: 4681554
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement of tumor growth and metastases by medroxyprogesterone acetate in transplanted uterine adenocarcinoma cells of the rat.
    Sekiya S; Yano A; Takamizawa H
    J Natl Cancer Inst; 1974 Jan; 52(1):297-8. PubMed ID: 4810970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ON PRE- AND POSTOPERATIVE ENDOXAN THERAPY OF CERVICAL AND UTERINE CARCINOMA WITH REFERENCE TO HISTOLOGICALLY DISCERNIBLE CHANGES].
    MUELLER R
    Zentralbl Gynakol; 1963 Oct; 85():1489-500. PubMed ID: 14095101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.